NCT05149859

Brief Summary

  • Binge Eating Disorder (BED) has been fairly recently introduced into the Diagnostic and Statistical Manual 5 psychiatric classification and its severity criteria are still not well established.
  • Moreover, it remains unclear whether BED is associated with greater metabolic severity or more somatic comorbidities, especially in obesity.
  • Improved BED severity staging could lead to a better definition of management strategies and , therefore, facilitate screening and care. The investigators' hypothesis is that an improved assessment of the impulsivity-compulsivity spectrum, emotional regulation, attentional impairment and somatic or psychiatric comorbidities will result in a better distinction between the severe form of BED (e.g., highly impulsive and somatically complicated) from milder form (e.g., more compulsive and less somatically complicated).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2023

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 8, 2021

Completed
1.2 years until next milestone

Study Start

First participant enrolled

March 7, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

October 9, 2024

Status Verified

October 1, 2024

Enrollment Period

2.6 years

First QC Date

November 19, 2021

Last Update Submit

October 7, 2024

Conditions

Keywords

Binge-Eating DisorderImpulsivityObesityAttentionEmotional regulation

Outcome Measures

Primary Outcomes (2)

  • Physical and psychological comorbidities

    Number of current associated comorbidities to patient with and without BED

    Inclusion

  • Binge Eating Scale score

    To assess binge eating severity based on the 16-item scale developed by Gormally et al in 1982

    Inclusion

Secondary Outcomes (18)

  • Body Mass Index in kg.m-2

    Inclusion

  • Percentage of fat mass in %

    Inclusion

  • Waist and hip circumferences in cm

    Inclusion

  • Triglycerides in mmol/L

    Inclusion

  • Cholesterol HDL and LDL in mmol/L

    Inclusion

  • +13 more secondary outcomes

Study Arms (2)

BED+ : Participants with obesity and binge eating disorder

Obesity is define by a BMI ≥ 30 kg.m-2 Binge eating disorder is defined by Binge Eating Disorder Screener (BEDS)-7 positive score and a Binge Eating Scale score \>16

Other: Observational

BED-: Participants with obesity but without binge eating disorder

Obesity is define by a BMI ≥ 30 kg.m-2 Binge eating disorder is defined by Binge Eating Disorder Screener (BEDS)-7 negative score and a Binge Eating Scale score \< 12

Other: Observational

Interventions

(no intervention)

BED+ : Participants with obesity and binge eating disorderBED-: Participants with obesity but without binge eating disorder

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be recruited from 2 sites: 1) the Institut Universitaire de Cardiologie et Pneumologie de Québec (IUCPQ; pre-bariatric surgery consultation and obesity care consultation); 2) the Centre d'Expertise Poids, Image et Alimentation (CEPIA), a clinic of the Institute of Nutrition and Functional Foods of Laval University (eatinig disorders consultation). The pre-selection of participants will be done using available data and screening tests deployed through the management frameworks already in place at the two sites. If needed, patients will be recruited by advertisement.

You may qualify if:

  • men or women aged 1
  • participants eligible for bariatric surgery (BMI\>40, or BMI\>35 with severe comorbidities)
  • participants scheduled for medical evaluation and treatment of obesity at the IUCPQ Obesity Clinic (BMI≥30)
  • participants scheduled for evaluation and treatment of BED at the CEPIA with obesity (BMI≥30)
  • for the group with BED: positive BEDS-7 screen and Binge Eating Scale score \>16;
  • for the control group: have a negative BEDS-7 screen and Binge Eating Scale score\<12
  • be fluent in French and able to consent.

You may not qualify if:

  • participants with severe neurological disorder and/or major neurocognitive deficits;
  • participants with previous bariatric surgery or with introduction or change of anti-obesity medication (liraglutide or naltrexone/bupropion) in the previous 3 months;
  • participants who cannot read and/or understand French;
  • participants under guardianship or curatorship;
  • participants already included in a study with a conflict of interest with this study;
  • inability to use a computer or iPad;
  • participants with a discordance between BEDS-7 (positive) and Binge Eating Scale (score ≤ 16) results found secondarily
  • participants who did not participate in part of the assessments (e.g., self-questionnaires or neurocognitive tests) and participants with a rate of missing data\>10%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre d'expertise Poids, Image et Alimentation (CEPIA)

Québec, Canada

NOT YET RECRUITING

IUCPQ

Québec, Canada

RECRUITING

MeSH Terms

Conditions

Binge-Eating DisorderImpulsive BehaviorObesityEmotional Regulation

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental DisordersBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSelf-ControlSocial Behavior

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • Sylvain Iceta

    Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 19, 2021

First Posted

December 8, 2021

Study Start

March 7, 2023

Primary Completion

October 1, 2025

Study Completion

December 31, 2025

Last Updated

October 9, 2024

Record last verified: 2024-10

Locations